GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), as well as the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound), may contribute to this uncomfortable symptom through their effects on digestion
Lets dive into the natural ways to harness the power of GLP-1
PlexusDx members receive ongoing support to manage any lingering symptoms throughout their treatment
What you do while youre on it, and how you transition off it, determines whether your results last
February 2, 2026: Gastroparesis is Most Common Injury in Lawsuits Against Ozempic and Other GLP-1 Drugs According to court documents, gastroparesis is the most frequently listed injury in complaints filed as part of the GLP-1 product liability litigation (MDL -3094), which includes Ozempic claims
These alterations hinder normal neuromuscular signaling, ultimately leading to the onset and development of MG
